CELGENE CORP /DE/
CIK 816284 · last filed 2020-07-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$247.64M
Companies
7
Total Filings
20
Lifetime Open-Market Net
$764.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACCELERON PHARMA INC (XLRN) Delisted | 10%+ Owner | 7,008,510 | $178.75 | $1.25B | $134.50M | 7 | 2020-07-13 |
| STRO | 10%+ Owner | 1,726,197 | $28.80 | $49.71M | $0 | 1 | 2018-10-02 |
| AGIO | 10%+ Owner | 6,718,433 | $29.46 | $197.93M | $618.13M | 4 | 2018-01-31 |
| CRISPR Therapeutics AG (PZRX) Delisted | 10%+ Owner | 8,727,849 | — | — | $1.29M | 3 | 2017-12-07 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | 10%+ Owner | 7,342,377 | — | — | $5.00M | 3 | 2017-04-13 |
| GLOBEIMMUNE INC (GBIM) Delisted | 10%+ Owner | 669,502 | — | — | $4.00M | 1 | 2014-07-08 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 3,267,974 | $1.47 | $4.80M | $2.00M | 1 | 2013-06-06 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-01 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +4,000,000 | $2.00M | EDGAR |
| 2016-10-27 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | +4,834,980 | $11.20M | EDGAR |
| 2016-10-26 | CRISPR Therapeutics AG (PZRX) Delisted | Mixed | +4,834,980 | $11.20M | EDGAR |
| 2016-01-11 | ACCELERON PHARMA INC (XLRN) Delisted | Buy (P) | +800,000 | $32.00M | EDGAR |
| 2015-05-04 | Alliqua BioMedical, Inc. (ALQA) Delisted | Buy (P) | +659,340 | $3.00M | EDGAR |
| 2014-07-08 | GLOBEIMMUNE INC (GBIM) Delisted | Mixed | +1,201,340 | $4.00M | EDGAR |
| 2014-01-29 | ACCELERON PHARMA INC (XLRN) Delisted | Buy (P) | +300,000 | $15.00M | EDGAR |
| 2013-09-26 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | +3,172,887 | $10.00M | EDGAR |
| 2013-07-30 | AGIO | Mixed | +14,157,777 | $38.25M | EDGAR |
| 2013-06-06 | Epizyme, Inc. (EPZM) Delisted | Mixed | +6,669,280 | $2.00M | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.